Share Price and Basic Stock Data
Last Updated: August 31, 2025, 1:31 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Dharani Sugars & Chemicals Ltd currently trades at ₹8.55 with a market capitalization of ₹28.4 Cr. The company’s financial metrics present a mixed picture. While the Return on Capital Employed (ROCE) stands at a respectable 12.9%, the Operating Profit Margin (OPM) at -2,387% and Net Profit at -93 indicate significant operational challenges. With Promoters holding a substantial stake at 61.55%, the company’s ownership structure appears stable, although the high level of borrowings at ₹436 Cr raises concerns about its leverage position.Strengths of Dharani Sugars & Chemicals include a decent ROCE and significant promoter holding, indicating alignment with long-term interests. However, the negative OPM and Net Profit signal operational inefficiencies and financial distress. A key risk lies in the company’s low Interest Coverage Ratio (ICR) of -1.07x, suggesting vulnerability to meeting debt obligations. Looking ahead, improving operational efficiency and reducing debt levels could enhance the company’s financial health and long-term prospects.In conclusion, while Dharani Sugars & Chemicals shows strengths in terms of ownership and ROCE, the company faces significant risks related to its financial performance and leverage. Investors should closely monitor the company’s efforts to enhance profitability and reduce debt to gauge its future sustainability in a challenging operating environment.Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Dharani Sugars & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 138 Cr. | 35.6 | 869/31.9 | 1.35 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,433 Cr. | 181 | 227/124 | 101 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 54.1 Cr. | 4.24 | 8.90/3.97 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,543.43 Cr | 261.66 | 352.53 | 100.76 | 0.22% | 11.73% | 22.92% | 9.18 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 3 | 2 | 3 | 3 | 2 | 1 | 1 | 2 | 3 | 6 | 5 | 8 | 6 |
| Operating Profit | -3 | -2 | -3 | -2 | -2 | -1 | -1 | -2 | -3 | -5 | -5 | -8 | -5 |
| OPM % | -228% | -4,975% | -7,575% | -1,904% | -2,223% | -4,500% | -2,387% | ||||||
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 36 | 1 | -8 | -0 | -1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 7 | 8 | 20 | 10 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | -8 | -8 | -8 | -7 | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -8 | -8 | -8 | -7 | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 |
| EPS in Rs | -2.43 | -2.34 | -2.45 | -2.23 | -2.23 | -2.06 | 33.97 | 6.87 | -4.05 | -7.82 | -5.67 | -10.48 | -6.20 |
Last Updated: August 20, 2025, 11:40 am
Below is a detailed analysis of the quarterly data for Dharani Sugars & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 2.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -5.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Mar 2025) to -5.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is -2,387.00%. The value appears strong and on an upward trend. It has increased from -4,500.00% (Mar 2025) to -2,387.00%, marking an increase of 2,113.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Mar 2025) to 0.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 20.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 10.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -21.00 Cr.. The value appears strong and on an upward trend. It has increased from -35.00 Cr. (Mar 2025) to -21.00 Cr., marking an increase of 14.00 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -21.00 Cr.. The value appears strong and on an upward trend. It has increased from -35.00 Cr. (Mar 2025) to -21.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -6.20. The value appears strong and on an upward trend. It has increased from -10.48 (Mar 2025) to -6.20, marking an increase of 4.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 524 | 364 | 364 | 509 | 482 | 316 | 110 | 31 | 40 | 1 | 0 | 0 | 1 |
| Expenses | 475 | 374 | 324 | 435 | 482 | 353 | 154 | 49 | 57 | 10 | 7 | 22 | 24 |
| Operating Profit | 49 | -11 | 40 | 74 | -0 | -37 | -44 | -18 | -18 | -9 | -7 | -22 | -23 |
| OPM % | 9% | -3% | 11% | 15% | -0% | -12% | -40% | -59% | -45% | -1,127% | -3,561% | -2,903% | -2,596% |
| Other Income | 2 | 18 | 9 | 8 | 17 | 4 | 35 | 6 | 1 | 0 | 156 | -7 | -9 |
| Interest | 65 | 66 | 68 | 75 | 79 | 75 | 2 | 2 | 0 | 0 | 6 | 42 | 45 |
| Depreciation | 29 | 21 | 23 | 23 | 23 | 23 | 22 | 23 | 23 | 22 | 22 | 22 | 22 |
| Profit before tax | -43 | -81 | -43 | -16 | -85 | -131 | -33 | -38 | -40 | -31 | 121 | -93 | -100 |
| Tax % | -21% | -8% | -72% | 12% | 1% | 14% | -10% | 0% | 0% | 0% | 0% | 0% | |
| Net Profit | -34 | -74 | -12 | -17 | -85 | -149 | -30 | -38 | -40 | -31 | 121 | -93 | -100 |
| EPS in Rs | -11.50 | -25.23 | -4.08 | -5.25 | -25.72 | -44.98 | -9.00 | -11.46 | -12.11 | -9.45 | 36.54 | -28.01 | -30.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -117.65% | 83.78% | -41.67% | -400.00% | -75.29% | 79.87% | -26.67% | -5.26% | 22.50% | 490.32% | -176.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 201.43% | -125.45% | -358.33% | 324.71% | 155.16% | -106.53% | 21.40% | 27.76% | 467.82% | -667.18% |
Dharani Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1025% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -7% |
| 3 Years: | % |
| TTM: | -117% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 12% |
| 3 Years: | -9% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:55 am
Balance Sheet
Last Updated: October 10, 2025, 1:55 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 42 |
| Reserves | 63 | -11 | 158 | 141 | 57 | -92 | -122 | -160 | -200 | -230 | -109 | -205 |
| Borrowings | 556 | 588 | 611 | 620 | 559 | 518 | 512 | 536 | 533 | 539 | 419 | 489 |
| Other Liabilities | 184 | 184 | 185 | 165 | 208 | 236 | 180 | 158 | 169 | 176 | 150 | 146 |
| Total Liabilities | 832 | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 |
| Fixed Assets | 477 | 462 | 629 | 610 | 604 | 583 | 558 | 538 | 514 | 492 | 470 | 448 |
| CWIP | 10 | 13 | 16 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 5 | 24 | 26 | 29 | 17 | 15 | 15 | 15 | 15 | 15 | 15 |
| Other Assets | 340 | 310 | 313 | 305 | 224 | 95 | 30 | 15 | 7 | 11 | 8 | 9 |
| Total Assets | 832 | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 |
Below is a detailed analysis of the balance sheet data for Dharani Sugars & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 9.00 Cr..
- For Reserves, as of Mar 2025, the value is -205.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -109.00 Cr. (Mar 2024) to -205.00 Cr., marking a decline of 96.00 Cr..
- For Borrowings, as of Mar 2025, the value is 489.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 419.00 Cr. (Mar 2024) to 489.00 Cr., marking an increase of 70.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 146.00 Cr.. The value appears to be improving (decreasing). It has decreased from 150.00 Cr. (Mar 2024) to 146.00 Cr., marking a decrease of 4.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 471.00 Cr.. The value appears to be improving (decreasing). It has decreased from 493.00 Cr. (Mar 2024) to 471.00 Cr., marking a decrease of 22.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 448.00 Cr.. The value appears to be declining and may need further review. It has decreased from 470.00 Cr. (Mar 2024) to 448.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
- For Other Assets, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Mar 2025, the value is 471.00 Cr.. The value appears to be declining and may need further review. It has decreased from 493.00 Cr. (Mar 2024) to 471.00 Cr., marking a decrease of 22.00 Cr..
However, the Borrowings (489.00 Cr.) are higher than the Reserves (-205.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -507.00 | -599.00 | -571.00 | -546.00 | -559.00 | -555.00 | -556.00 | -554.00 | -551.00 | -548.00 | -426.00 | -457.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 43 | 55 | 40 | 35 | 49 | 57 | 60 | 42 | 2,008 | ||
| Inventory Days | 235 | 246 | 335 | 226 | 133 | 32 | 25 | 28 | 7 | |||
| Days Payable | 101 | 154 | 187 | 77 | 114 | 140 | 400 | 1,263 | 954 | |||
| Cash Conversion Cycle | 149 | 134 | 203 | 190 | 53 | -59 | -318 | -1,175 | -906 | 2,008 | ||
| Working Capital Days | -76 | -97 | -97 | -132 | -245 | -565 | -2,142 | -7,763 | -6,175 | -302,768 | ||
| ROCE % | 3% | -2% | 4% | 7% | -1% | -11% | -15% | -9% | -10% | -9% | -8% | -13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -24.60 | 36.54 | -9.44 | -12.11 | -11.46 |
| Diluted EPS (Rs.) | -24.60 | 36.54 | -9.44 | -12.11 | -11.46 |
| Cash EPS (Rs.) | -17.08 | 38.35 | -9.44 | -5.07 | -4.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -39.33 | -22.82 | -59.37 | -50.10 | -38.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -39.33 | -22.82 | -59.37 | -50.10 | -38.16 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.24 | 11.95 | 9.36 |
| PBDIT / Share (Rs.) | -5.03 | -1.93 | -2.74 | -5.06 | -3.77 |
| PBIT / Share (Rs.) | -10.36 | -3.73 | -2.74 | -12.10 | -10.82 |
| PBT / Share (Rs.) | -22.40 | 36.54 | -9.44 | -12.11 | -11.46 |
| Net Profit / Share (Rs.) | -22.40 | 36.54 | -9.44 | -12.11 | -11.46 |
| PBDIT Margin (%) | 0.00 | 0.00 | -1107.47 | -42.38 | -40.30 |
| PBIT Margin (%) | 0.00 | 0.00 | -1108.63 | -101.28 | -115.56 |
| PBT Margin (%) | 0.00 | 0.00 | -3817.05 | -101.32 | -122.34 |
| Net Profit Margin (%) | 0.00 | 0.00 | -3817.05 | -101.32 | -122.34 |
| Return on Networth / Equity (%) | 0.00 | -160.10 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | -17.01 | -5.39 | 5.29 | 28.47 | 35.44 |
| Return On Assets (%) | -19.73 | 24.63 | -6.05 | -7.50 | -6.70 |
| Long Term Debt / Equity (X) | -2.21 | -3.78 | -0.03 | -0.03 | -0.04 |
| Total Debt / Equity (X) | -2.67 | -5.52 | -2.74 | -3.21 | -4.23 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.07 | 0.05 |
| Current Ratio (X) | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Quick Ratio (X) | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | -0.01 | 27.52 | 6.52 |
| Interest Coverage Ratio (X) | -0.49 | -0.28 | -0.40 | -1355.96 | -5.94 |
| Interest Coverage Ratio (Post Tax) (X) | -1.03 | -0.55 | -0.40 | -3240.66 | -17.05 |
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 588.30 | 551.77 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 14.83 | 17.75 |
| EV / EBITDA (X) | 0.00 | 0.00 | 0.00 | -34.99 | -44.03 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 1.39 | 0.68 |
| Price / BV (X) | 0.00 | 0.00 | 0.00 | -0.33 | -0.16 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 1.39 | 0.68 |
| EarningsYield | 0.00 | 0.00 | 0.00 | -0.72 | -1.77 |
After reviewing the key financial ratios for Dharani Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -24.60. This value is below the healthy minimum of 5. It has decreased from 36.54 (Mar 24) to -24.60, marking a decrease of 61.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is -24.60. This value is below the healthy minimum of 5. It has decreased from 36.54 (Mar 24) to -24.60, marking a decrease of 61.14.
- For Cash EPS (Rs.), as of Mar 25, the value is -17.08. This value is below the healthy minimum of 3. It has decreased from 38.35 (Mar 24) to -17.08, marking a decrease of 55.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -39.33. It has decreased from -22.82 (Mar 24) to -39.33, marking a decrease of 16.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -39.33. It has decreased from -22.82 (Mar 24) to -39.33, marking a decrease of 16.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -5.03. This value is below the healthy minimum of 2. It has decreased from -1.93 (Mar 24) to -5.03, marking a decrease of 3.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -10.36. This value is below the healthy minimum of 0. It has decreased from -3.73 (Mar 24) to -10.36, marking a decrease of 6.63.
- For PBT / Share (Rs.), as of Mar 25, the value is -22.40. This value is below the healthy minimum of 0. It has decreased from 36.54 (Mar 24) to -22.40, marking a decrease of 58.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -22.40. This value is below the healthy minimum of 2. It has decreased from 36.54 (Mar 24) to -22.40, marking a decrease of 58.94.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -160.10 (Mar 24) to 0.00, marking an increase of 160.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -17.01. This value is below the healthy minimum of 10. It has decreased from -5.39 (Mar 24) to -17.01, marking a decrease of 11.62.
- For Return On Assets (%), as of Mar 25, the value is -19.73. This value is below the healthy minimum of 5. It has decreased from 24.63 (Mar 24) to -19.73, marking a decrease of 44.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.21. This value is below the healthy minimum of 0.2. It has increased from -3.78 (Mar 24) to -2.21, marking an increase of 1.57.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.67. This value is within the healthy range. It has increased from -5.52 (Mar 24) to -2.67, marking an increase of 2.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 1.5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.49. This value is below the healthy minimum of 3. It has decreased from -0.28 (Mar 24) to -0.49, marking a decrease of 0.21.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 3. It has decreased from -0.55 (Mar 24) to -1.03, marking a decrease of 0.48.
- For Enterprise Value (Cr.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dharani Sugars & Chemicals Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -17.01% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 352.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.67
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
FAQ
What is the intrinsic value of Dharani Sugars & Chemicals Ltd?
Dharani Sugars & Chemicals Ltd's intrinsic value (as of 09 September 2025) is 90.33 which is 956.49% higher the current market price of 8.55, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.4 Cr. market cap, FY2025-2026 high/low of /, reserves of ₹-205 Cr, and liabilities of 471 Cr.
What is the Market Cap of Dharani Sugars & Chemicals Ltd?
The Market Cap of Dharani Sugars & Chemicals Ltd is 28.4 Cr..
What is the current Stock Price of Dharani Sugars & Chemicals Ltd as on 09 September 2025?
The current stock price of Dharani Sugars & Chemicals Ltd as on 09 September 2025 is 8.55.
What is the High / Low of Dharani Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dharani Sugars & Chemicals Ltd stocks is /.
What is the Stock P/E of Dharani Sugars & Chemicals Ltd?
The Stock P/E of Dharani Sugars & Chemicals Ltd is .
What is the Book Value of Dharani Sugars & Chemicals Ltd?
The Book Value of Dharani Sugars & Chemicals Ltd is 49.2.
What is the Dividend Yield of Dharani Sugars & Chemicals Ltd?
The Dividend Yield of Dharani Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Dharani Sugars & Chemicals Ltd?
The ROCE of Dharani Sugars & Chemicals Ltd is 12.9 %.
What is the ROE of Dharani Sugars & Chemicals Ltd?
The ROE of Dharani Sugars & Chemicals Ltd is %.
What is the Face Value of Dharani Sugars & Chemicals Ltd?
The Face Value of Dharani Sugars & Chemicals Ltd is 10.0.